Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
0.730
-0.019 (-2.51%)
Feb 21, 2025, 4:00 PM EST - Market closed
Century Therapeutics Market Cap
Century Therapeutics has a market cap or net worth of $62.08 million as of February 21, 2025. Its market cap has decreased by -77.20% in one year.
Market Cap
62.08M
Enterprise Value
-81.44M
1-Year Change
-77.20%
Ranking
Category
Stock Price
$0.73
Market Cap Chart
Since the IPO on June 18, 2021, Century Therapeutics's market cap has decreased from $1.05B to $62.08M, a decrease of -94.09%. That is a compound annual growth rate of -53.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 62.08M | -27.71% |
| Dec 31, 2024 | 85.88M | -56.77% |
| Dec 29, 2023 | 198.65M | -34.34% |
| Dec 30, 2022 | 302.54M | -65.09% |
| Dec 31, 2021 | 866.61M | -17.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.92B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |